Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue

Molecular Metabolism

Volumn 4, Issue 11, 2015, Pages 779-794

  Kaplan, Jennifer L ^a   Marshall, Melissa A ^a   McSkimming, Chantel C ^a   Harmon, Daniel B ^a,b   Garmey, James C ^a   Oldham, Stephanie N ^a   Hallowell, Peter ^a   McNamara, Coleen A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adipocyte progenitors; Id3; Inflammation; MCP 1; Obesity

Indexed keywords

BETA1 INTEGRIN; CD24 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1; MONOCYTE CHEMOTACTIC PROTEIN 1; STEM CELL ANTIGEN 1;

ADIPOCYTE PROGENITOR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BIOACCUMULATION; CELL COUNT; CELL EXPANSION; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VIVO STUDY; INTRAABDOMINAL FAT; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; SUBCUTANEOUS FAT;

EID: 84945457201     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.07.010     Document Type: Article

References (70)

1. Jia H., Lubetkin E.I. Trends in quality-adjusted life-years lost contributed by smoking and obesity. American Journal of Preventive Medicine 2010, 38:138-144.
2. Kaminski D.A., Randall T.D. Adaptive immunity and adipose tissue biology. Trends in Immunology 2010, 31:384-390.
3. Jiao P., Chen Q., Shah S., Du J., Tao B., Tzameli I., et al. Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 2009, 58:104-115.
4. Nomura S., Shouzu A., Omoto S., Nishikawa M., Fukuhara S. Significance of chemokines and activated platelets in patients with diabetes. Clinical & Experimental Immunology 2000, 121:437-443.
5. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., et al. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obesity Research 2005, 13:1311-1320.
6. Dalmas E., Clement K., Guerre-Millo M. Defining macrophage phenotype and function in adipose tissue. Trends in Immunology 2011, 32:307-314.
7. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. Journal of Clinical Investigation 2006, 116:1494-1505.
8. Singer K., DelProposto J., Morris D.L., Zamarron B., Mergian T., Maley N., et al. Diet-induced obesity promotes myelopoiesis in hematopoietic stem cells. Molecular Metabolism 2014, 3:664-675.
9. Fujisaka S., Usui I., Bukhari A., Ikutani M., Oya T., Kanatani Y., et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009, 58:2574-2582.
10. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007, 117:175-184.
11. Coenen K.R., Gruen M.L., Chait A., Hasty A.H. Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes 2007, 56:564-573.
12. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis, Thrombosis and Vascular Biology 2008, 28:1304-1310.
13. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. Journal of Biological Chemistry 2007, 282:35279-35292.
14. Gao D., Trayhurn P., Bing C. 1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. International Journal of Obesity (London) 2013, 37:357-365.
15. Cutchins A., Harmon D.B., Kirby J.L., Doran A.C., Oldham S.N., Skaflen M., et al. Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion. Arteriosclerosis, Thrombosis and Vascular Biology 2012, 32:317-324.
16. Svendstrup M., Vestergaard H. The potential role of inhibitor of differentiation-3 in human adipose tissue remodeling and metabolic health. Molecular Genetics and Metabolism 2014, 113:149-154.
17. Benezra R., Davis R.L., Lockshon D., Turner D.L., Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990, 61:49-59.
18. Ruzinova M.B., Benezra R. Id proteins in development, cell cycle and cancer. Trends in Cell Biology 2003, 13:410-418.
19. Doran A.C., Meller N., Cutchins A., Deliri H., Slayton R.P., Oldham S.N., et al. The helix-loop-helix factors Id3 and E47 are novel regulators of adiponectin. Circulation Research 2008, 103:624-634.
20. Moldes M., Boizard M., Liepvre X.L., Feve B., Dugail I., Pairault J. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes. Biochemical Journal 1999, 344(Pt 3):873-880.
21. Das J.K., Felty Q. PCB153-induced overexpression of ID3 contributes to the development of microvascular lesions. PLoS One 2014, 9:e104159.
22. Zimmerlin L., Donnenberg V.S., Donnenberg A.D. Rare event detection and analysis in flow cytometry: bone marrow mesenchymal stem cells, breast cancer stem/progenitor cells in malignant effusions, and pericytes in disaggregated adipose tissue. Methods in Molecular Biology 2011, 699:251-273.
23. Forrest S.T., Taylor A.M., Sarembock I.J., Perlegas D., McNamara C.A. Phosphorylation regulates Id3 function in vascular smooth muscle cells. Circulation Research 2004, 95:557-559.
24. Prabhu S., Ignatova A., Park S.T., Sun X.H. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Molecular Cell Biology 1997, 17:5888-5896.
25. Church C.D., Berry R., Rodeheffer M.S. Isolation and study of adipocyte precursors. Methods in Enzymology 2014, 537:31-46.
26. Stella C.C., Cazzola M., De Fabritiis P., De Vincentiis A., Gianni A.M., Lanza F., et al. CD34-positive cells: biology and clinical relevance. Haematologica 1995, 80:367-387.
27. Davies L.C., Jenkins S.J., Allen J.E., Taylor P.R. Tissue-resident macrophages. Nature Immunology 2013, 14:986-995.
28. Rodeheffer M.S., Birsoy K., Friedman J.M. Identification of white adipocyte progenitor cells in vivo. Cell 2008, 135:240-249.
29. Berry R., Rodeheffer M.S. Characterization of the adipocyte cellular lineage in vivo. Nature Cell Biology 2013, 15:302-308.
30. Berry R., Jeffery E., Rodeheffer M.S. Weighing in on adipocyte precursors. Cell Metabolism 2014, 19:8-20.
31. Moldes M., Lasnier F., Feve B., Pairault J., Djian P. Id3 prevents differentiation of preadipose cells. Molecular and Cellular Biology 1997, 17:1796-1804.
32. O'Brien C.A., Kreso A., Ryan P., Hermans K.G., Gibson L., Wang Y., et al. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell 2012, 21:777-792.
33. Waga S., Hannon G.J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994, 369:574-578.
34. Yu R., Kim C.S., Kwon B.S., Kawada T. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity (Silver Spring) 2006, 14:1353-1362.
35. Mitterberger M.C., Lechner S., Mattesich M., Kaiser A., Probst D., Wenger N., et al. DLK1(PREF1) is a negative regulator of adipogenesis in CD105(+)/CD90(+)/CD34(+)/CD31(-)/FABP4(-) adipose-derived stromal cells from subcutaneous abdominal fat pats of adult women. Stem Cell Research 2012, 9:35-48.
36. Perez L.M., Bernal A., San Martin N., Galvez B.G. Obese-derived ASCs show impaired migration and angiogenesis properties. Archives in Physiology and Biochemistry 2013, 119:195-201.
37. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation 2006, 116:115-124.
38. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitamins & Hormones 2006, 74:443-477.
39. Cushing S.D., Berliner J.A., Valente A.J., Territo M.C., Navab M., Parhami F., et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:5134-5138.
40. Schipper H.S., Prakken B., Kalkhoven E., Boes M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends in Endocrinology & Metabolism 2012, 23:407-415.
41. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116:829-840.
42. Pucci F., Venneri M.A., Biziato D., Nonis A., Moi D., Sica A., et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 2009, 114:901-914.
43. Nakao S., Kuwano T., Tsutsumi-Miyahara C., Ueda S., Kimura Y.N., Hamano S., et al. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. Journal of Clinical Investigation 2005, 115:2979-2991.
44. Tang W., Zeve D., Suh J.M., Bosnakovski D., Kyba M., Hammer R.E., et al. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322:583-586.
45. Tran K.V., Gealekman O., Frontini A., Zingaretti M.C., Morroni M., Giordano A., et al. The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metabolism 2012, 15:222-229.
46. Han J., Lee J.E., Jin J., Lim J.S., Oh N., Kim K., et al. The spatiotemporal development of adipose tissue. Development 2011, 138:5027-5037.
47. Valet P., Tavernier G., Castan-Laurell I., Saulnier-Blache J.S., Langin D. Understanding adipose tissue development from transgenic animal models. Journal of Lipid Research 2002, 43:835-860.
48. Jeffery E., Church C.D., Holtrup B., Colman L., Rodeheffer M.S. Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity. Nature Cell Biology 2015, 17:376-385.
49. Fujiwara K., Hasegawa K., Ohkumo T., Miyoshi H., Tseng Y.H., Yoshikawa K. Necdin controls proliferation of white adipocyte progenitor cells. PLoS One 2012, 7:e30948.
50. Naaz A., Holsberger D.R., Iwamoto G.A., Nelson A., Kiyokawa H., Cooke P.S. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB Journal 2004, 18:1925-1927.
51. Kirk E.A., Sagawa Z.K., McDonald T.O., O'Brien K.D., Heinecke J.W. Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes 2008, 57:1254-1261.
52. Oh D.Y., Morinaga H., Talukdar S., Bae E.J., Olefsky J.M. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012, 61:346-354.
53. Chen G.Y., Chen X., King S., Cavassani K.A., Cheng J., Zheng X., et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology 2011, 29:428-435.
54. Zhou Q., Rammohan K., Lin S., Robinson N., Li O., Liu X., et al. CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:15041-15046.
55. Fang X., Zheng P., Tang J., Liu Y. CD24: from A to Z. Cellular & Molecular Immunology 2010, 7:100-103.
56. Suzuki T., Kiyokawa N., Taguchi T., Sekino T., Katagiri Y.U., Fujimoto J. CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. Journal of Immunology 2001, 166:5567-5577.
57. Perez L.M., Bernal A., San Martin N., Lorenzo M., Fernandez-Veledo S., Galvez B.G. Metabolic rescue of obese adipose-derived stem cells by Lin28/Let7 pathway. Diabetes 2013, 62:2368-2379.
58. Gesta S., Bluher M., Yamamoto Y., Norris A.W., Berndt J., Kralisch S., et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6676-6681.
59. Tchkonia T., Lenburg M., Thomou T., Giorgadze N., Frampton G., Pirtskhalava T., et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. American Journal of Physiology-Endocrinology and Metabolism 2007, 292:E298-E307.
60. Cancello R., Tordjman J., Poitou C., Guilhem G., Bouillot J.L., Hugol D., et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55:1554-1561.
61. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiology Reviews 2011, 91:221-264.
62. Sun J., Feng A., Chen S., Zhang Y., Xie Q., Yang M., et al. Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-beta1. Cellular & Molecular Immunology 2013, 10:176-182.
63. Kahles F., Findeisen H.M., Bruemmer D. Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes. Molecular Metabolism 2014, 3:384-393.
64. Nomiyama T., Perez-Tilve D., Ogawa D., Gizard F., Zhao Y., Heywood E.B., et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. Journal of Clinical Investigation 2007, 117:2877-2888.
65. Han C.Y., Subramanian S., Chan C.K., Omer M., Chiba T., Wight T.N., et al. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 2007, 56:2260-2273.
66. Kodama K., Horikoshi M., Toda K., Yamada S., Hara K., Irie J., et al. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:7049-7054.
67. Grundy S.M. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002, 105:2696-2698.
68. Vucenik I., Stains J.P. Obesity and cancer risk: evidence, mechanisms, and recommendations. Annals of the New York Academy of Sciences 2012, 1271:37-43.
69. Procaccini C., Carbone F., Galgani M., La Rocca C., De Rosa V., Cassano S., et al. Obesity and susceptibility to autoimmune diseases. Expert Review of Clinical Immunology 2011, 7:287-294.
70. Wernstedt Asterholm I., Tao C., Morley T.S., Wang Q.A., Delgado-Lopez F., Wang Z.V., et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metabolism 2014, 20:103-118.